Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy

Bằng Rehman, Hasan, Silk, Ann W., Kane, Michael P., Kaufman, Howard L.
Xuất bản năm J Immunother Cancer (2016)

Association of Rising Cost and Use of Oral Anticancer Drugs With Medicare Part D Spending From 2013 Through 2017

Bằng Seiger, Kira, Mostaghimi, Arash, Silk, Ann W., Schmults, Chrysalyne D., Ruiz, Emily Stamell
Xuất bản năm JAMA Oncol (2019)

Ipilimumab and radiation therapy for melanoma brain metastases

Bằng Silk, Ann W, Bassetti, Michael F, West, Brady T, Tsien, Christina I, Lao, Christopher D
Được phát hành 2013

The Clinical Management of Multiple Melanoma Brain Metastases: A Systematic Review

Bằng Goyal, Sharad, Silk, Ann W., Tian, Sibo, Mehnert, Janice, Danish, Shabbar, Ranjan, Sinthu, Kaufman, Howard L.
Xuất bản năm JAMA Oncol (2015)

Impact of corticosteroids on allograft protection in renal transplant patients receiving anti-PD-1 immunotherapy

Bằng Danesh, Melissa J., Mulvaney, Patrick M., Murakami, Naoka, Riella, Leonardo V., Silk, Ann W., Hanna, Glenn J., Schmults, Chrysalyne D.
Xuất bản năm Cancer Immunol Immunother (2020)

Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI)

Bằng Hanna, Glenn J., Ruiz, Emily S., LeBoeuf, Nicole R., Thakuria, Manisha, Schmults, Chrysalyne D., Decaprio, James A., Silk, Ann W.
Xuất bản năm Br J Cancer (2020)

Oncolytic Viruses—Natural and Genetically Engineered Cancer Immunotherapies

Bằng Jhawar, Sachin R., Thandoni, Aditya, Bommareddy, Praveen K., Hassan, Suemair, Kohlhapp, Frederick J., Goyal, Sharad, Schenkel, Jason M., Silk, Ann W., Zloza, Andrew
Xuất bản năm Front Oncol (2017)

Rescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case series

Bằng LoPiccolo, Jaclyn, Schollenberger, Megan D., Dakhil, Sumia, Rosner, Samuel, Ali, Osama, Sharfman, William H., Silk, Ann W., Bhatia, Shailender, Lipson, Evan J.
Xuất bản năm J Immunother Cancer (2019)

Predictors of immunotherapy benefit in Merkel cell carcinoma

Bằng Kacew, Alec J., Dharaneeswaran, Harita, Starrett, Gabriel J., Thakuria, Manisha, LeBoeuf, Nicole R., Silk, Ann W., DeCaprio, James A., Hanna, Glenn J.
Xuất bản năm Oncotarget (2020)

The Association of Radiation Dose-Fractionation and Immunotherapy Use With Overall Survival in Metastatic Melanoma Patients

Bằng Wang, Shang-Jui, Jhawar, Sachin R, Rivera-Nunez, Zorimar, Silk, Ann W, Byun, John, Miller, Eric, Blakaj, Dukagjin, Parikh, Rahul R, Weiner, Joseph, Goyal, Sharad
Xuất bản năm Cureus (2020)

Efficacy and safety of high-dose interleukin-2 treatment in patients with a history of brain metastases from renal cell carcinoma

Bằng Chandar, Ashwin, Silk, Ann W, Clark, Joseph I, Daniels, Gregory A, McDermott, David F, Morse, Michael, Wong, Michael KK, Stein, Mark, Mehnert, Janice, Danish, Shabbar, Aung, Sandra, Kaufman, Howard L
Xuất bản năm J Immunother Cancer (2015)

Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer

Bằng Wang, Shang-Jui, Khullar, Karishma, Kim, Sinae, Yegya-Raman, Nikhil, Malhotra, Jyoti, Groisberg, Roman, Crayton, Samuel H, Silk, Ann W, Nosher, John L, Gentile, Michael A, Mehnert, Janice M, Jabbour, Salma K
Xuất bản năm J Immunother Cancer (2020)

A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma

Bằng Mehnert, Janice M., Silk, Ann W., Lee, J. H., Dudek, Liesel, Jeong, Byeong-Seon, Li, Jiadong, Schenkel, Jason M., Sadimin, Evita, Kane, Michael, Lin, Hongxia, Shih, Weichung J., Zloza, Andrew, Chen, Suzie, Goydos, James. S.
Xuất bản năm Pigment Cell Melanoma Res (2018)

High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma

Bằng Silk, Ann W., Kaufman, Howard L., Curti, Brendan, Mehnert, Janice M., Margolin, Kim, McDermott, David, Clark, Joseph, Newman, Jenna, Bommareddy, Praveen K., Denzin, Lisa, Najmi, Saltanat, Haider, Azra, Shih, Weichung, Kane, Michael P., Zloza, Andrew
Xuất bản năm Front Oncol (2020)

PHASE I TRIAL OF ALT-803, A NOVEL RECOMBINANT INTERLEUKIN-15 COMPLEX, IN PATIENTS WITH ADVANCED SOLID TUMORS

Bằng Margolin, Kim, Morishima, Chihiro, Velcheti, Vamsidhar, Miller, Jeffrey S., Lee, Sylvia M., Silk, Ann W., Holtan, Shernan G., Lacroix, Andreanne M., Fling, Steven P., Kaiser, Judith C., Egan, Jack O., Jones, Monica, Rhode, Peter R., Rock, Amy D., Cheever, Martin A., Wong, Hing C., Ernstoff, Marc S.
Xuất bản năm Clin Cancer Res (2018)

Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition

Bằng Buchbinder, Elizabeth I., Dutcher, Janice P., Daniels, Gregory A., Curti, Brendan D., Patel, Sapna P., Holtan, Shernan G., Miletello, Gerald P., Fishman, Mayer N., Gonzalez, Rene, Clark, Joseph I., Richart, John M., Lao, Christopher D., Tykodi, Scott S., Silk, Ann W., McDermott, David F.
Xuất bản năm J Immunother Cancer (2019)

Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer

Bằng Panda, Anshuman, Mehnert, Janice M, Hirshfield, Kim M, Riedlinger, Greg, Damare, Sherri, Saunders, Tracie, Kane, Michael, Sokol, Levi, Stein, Mark N, Poplin, Elizabeth, Rodriguez-Rodriguez, Lorna, Silk, Ann W, Aisner, Joseph, Chan, Nancy, Malhotra, Jyoti, Frankel, Melissa, Kaufman, Howard L, Ali, Siraj, Ross, Jeffrey S, White, Eileen P, Bhanot, Gyan, Ganesan, Shridar
Xuất bản năm J Natl Cancer Inst (2017)

Clinical characterization of colitis arising from anti-PD-1 based therapy

Bằng Wang, Daniel Y, Mooradian, Meghan J, Kim, DaeWon, Shah, Neil J, Fenton, Sarah E, Conry, Robert M, Mehta, Rutika, Silk, Ann W., Zhou, Alice, Compton, Margaret L, Al-Rohil, Rami N, Lee, Sunyoung, Voorhees, Amber L, Ha, Lisa, McKee, Svetlana, Norrell, Jacqueline T, Mehnert, Janice, Puzanov, Igor, Sosman, Jeffrey A, Chandra, Sunandana, Gibney, Geoffrey T, Rapisuwon, Suthee, Eroglu, Zeynep, Sullivan, Ryan, Johnson, Douglas B
Xuất bản năm Oncoimmunology (2018)

First-in-human Clinical Trial of Oral ONC201 in Patients with Refractory Solid Tumors

Bằng Stein, Mark N., Bertino, Joseph, Kaufman, Howard L., Mayer, Tina M., Moss, Rebecca A., Silk, Ann W., Chan, Nancy, Malhotra, Jyoti, Rodriguez, Lorna, Aisner, Joseph, Aiken, Robert, Haffty, Bruce G., DiPaola, Robert S., Saunders, Tracie, Zloza, Andrew, Damare, Sherri, Beckett, Yasmeen, Yu, Bangning, Najmi, Saltanat, Gabel, Christian, Dickerson, Siobhan, Zheng, Ling, El-Deiry, Wafik S., Allen, Joshua E., Stogniew, Martin, Oster, Wolfgang, Mehnert, Janice M.
Xuất bản năm Clin Cancer Res (2017)

Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration

Bằng Stein, Mark N., Malhotra, Jyoti, Tarapore, Rohinton S., Malhotra, Usha, Silk, Ann W., Chan, Nancy, Rodriguez, Lorna, Aisner, Joseph, Aiken, Robert D., Mayer, Tina, Haffty, Bruce G., Newman, Jenna H., Aspromonte, Salvatore M., Bommareddy, Praveen K., Estupinian, Ricardo, Chesson, Charles B., Sadimin, Evita T., Li, Shengguo, Medina, Daniel J., Saunders, Tracie, Frankel, Melissa, Kareddula, Aparna, Damare, Sherrie, Wesolowsky, Elayne, Gabel, Christian, El-Deiry, Wafik S., Prabhu, Varun V., Allen, Joshua E., Stogniew, Martin, Oster, Wolfgang, Bertino, Joseph R., Libutti, Steven K., Mehnert, Janice M., Zloza, Andrew
Xuất bản năm J Immunother Cancer (2019)